United States Food and Drug Administration and the Pharmaceutical Industry [PDF]
BMJ, 1961 Jane Garland
openaire +4 more sources
United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies [PDF]
Current Problems in Cancer, 2013 The United States Food and Drug Administration (FDA) has approved 19 oral kinase inhibitors (KIs) for the treatment of malignancies in hematology and oncology as of May 2013, see Table 1. We review the general principles and guidelines for using KIs for cancer treatment. This article is not designed for cross-trial comparison or to make recommendations
Woondong Jeong +2 more
openaire +4 more sources
An introspection of quality of novel drug approvals by United States Food and Drug Administration
International Journal of Basic & Clinical Pharmacology, 2018 Background: United States Food and Drug Administration (FDA) is the fastest drug review agency in the world. FDA is responsible for protection of the public health by assuring that foods are safe, wholesome, sanitary and properly labelled. Approved Novel drugs are often innovative products that serve unmet medical needs or otherwise help to advance ...
Ajay Kumar Shukla, Rekha Mehani
openaire +4 more sources
United States Food and Drug Administration Approval Summary: Bortezomib for the Treatment of Progressive Multiple Myeloma after One Prior Therapy [PDF]
Clinical Cancer Research, 2006 Robert C. Kane +3 more
openalex +2 more sources
Strength of clinical evidence supporting the United States Food and Drug Administration Accelerated Approvals from 2015 to 2022. [PDF]
BMC MedZhang X +8 more
europepmc +2 more sources
Intraspinal steroids: history, efficacy, accidentality, and controversy with review of United States Food and Drug Administration reports [PDF]
Journal of Neurology Neurosurgery & Psychiatry, 2001 Dewey A. Nelson
openalex +2 more sources
United States Food and Drug Administration Regulation of Clinical Software in the Era of Artificial Intelligence and Machine Learning. [PDF]
Mayo Clin Proc Digit HealthSingh V, Cheng S, Kwan AC, Ebinger J.
europepmc +2 more sources
Abemaciclib-associated kidney injuries: A retrospective analysis of the United States Food and Drug Administration adverse events reporting system. [PDF]
J Int Med ResXu X +7 more
europepmc +2 more sources
Comparison of Adverse Events Among Angiotensin Receptor Blockers in Hypertension Using the United States Food and Drug Administration Adverse Event Reporting System. [PDF]
CureusOgura T, Shiraishi C.
europepmc +2 more sources
Data from the United States Food and Drug Administration
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2005 Jenny Zheng
openaire +4 more sources